The Capy widget is a favorite. If you are in your GLP-1 journey, this app will be your best friend
The woman, who lives in Louisiana, lost around 150 pounds on the two medications, according to her attorney, Paul Pennock, a New York City-based attorney for Morgan & Morgan, According to the lawsuit, the woman, who has not been officially diagnosed with gastroparesis, suffered "severe gastrointestinal events," including, "severe vomiting, stomach pain, [and] gastrointestinal burning." "Her problems have been so severe that she's been to the emergency room multiple times, including last week," Pennock told ABC News Wednesday
Retatrutide is a triple-agonist weight loss drug thats currently undergoing clinical trials and is not yet FDA approved
While type 2 diabetes and obesity are the main conditions that GLP-1 agonists are used to treat, there is some evidence to suggest that they may also have additional health advantages aside from meaningful weight loss and metabolic health